Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy

By Peyromaure M.   Weibing S.   Sebe P.   Verpillat P.   Toublanc M.   Dauge M.-C.   Boccon-Gibod L.   Ravery V.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 409-413

Elsevier

Access to resources Recommend Favorite

Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy

By Wu C.S.   Pollack A.   Czerniak B.   Chyle V.   Zagars G.K.   Dinney C.P.N.   Hu S.-X.   Benedict W.F.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

By Slaton J.W.   Benedict W.F.   Dinney C.P.N.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 852-859

Elsevier

Access to resources Recommend Favorite

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

By Shariat S.F.   Kim J.   Raptidis G.   Ayala G.E.   Lerner S.P.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1140-1145

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for bladder cancer

By Black Peter   Brown Gordon   Grossman H.   Dinney Colin  

World Journal of Urology, Vol. 24, Iss. 5, 2006-11 ,pp. : 531-542

Springer Publishing Company

Access to resources Recommend Favorite